Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin

Luigi Cavenaghi, Angelo Corti, Giovanni Cassani

Research output: Contribution to journalArticlepeer-review


A solid phase enzyme receptor assay (SPERA) for teicoplanin has been developed and recently presented in a kit form. The assay relies on the competition between antibiotic present in the biological fluid and peroxidase labelled teicoplanin for albumin-ε-amino-caproyl-D-alanyl-D-alanine (BSA-ε-ACA-D-Ala-D-Ala), a synthetic analog of the biological receptor. The kit contains BSA-ε-ACA-D-Ala-D-Ala coated microplates together with all the necessary reagents. The limit of detection of the SPERA is 0·5mg1 -1. The microbiological assay for teicoplanin uses Bacillus subtilis ATCC 6633 as test organism and a high salt medium to ensure a low limit of detection of 0·05 mg1 -1. The previously established correlation between the two methods has been confirmed using the kits on 280 serum and 216 urine samples with concentrations up to 500mg1 -1.

Original languageEnglish
Pages (from-to)85-89
Number of pages5
JournalJournal of Hospital Infection
Issue numberSUPPL. A
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin'. Together they form a unique fingerprint.

Cite this